Apyx Medical Corp (APYX) › Cost of RevenueApyx Medical Corp (APYX) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2009: $15.10M2010: $14.24M2011: $14.68M2012: $16.34M2013: $14.46M2014: $18.69M2015: $16.96M2016: $3.70M2017: $3.28M2018: $5.78M2019: $9.14M2020: $10.21M2021: $14.92M2022: $15.38M2023: $18.59M2024: $18.74M2025: $19.80M$19.80M2009Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$19.80M+5.6%2024$18.74M+0.8%2023$18.59M+20.9%2022$15.38M+3.1%2021$14.92M+46.1%2020$10.21M+11.7%2019$9.14M+58.2%2018$5.78M+76.4%2017$3.28M-11.5%2016$3.70M-78.2%2015$16.96M-9.2%2014$18.69M+29.2%2013$14.46M-11.5%2012$16.34M+11.3%2011$14.68M+3.1%2010$14.24M-5.7%2009$15.10M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share